Based on its status as canonical SREBF1/2 target, it is not surprising that LDLR features among the robustly down‐regulated transcripts, (Figure S1A), thereby representing an unlikely contributor to the scavenging response, at least in our AML panel. This evidence concerns the gene SREBF1 and acute myeloid leukemia.